Hobbs M R, Pole A R, Pidwirny G N, Rosen I B, Zarbo R J, Coon H, Heath H, Leppert M, Jackson C E
Division of Endocrinology, Metabolism, and Diabetes, Department of Internal Medicine, University of Utah, Salt Lake City, UT 84132, USA.
Am J Hum Genet. 1999 Feb;64(2):518-25. doi: 10.1086/302259.
Hyperparathyroidism-jaw tumor syndrome (HPT-JT) is an autosomal dominant disease characterized by the development of multiple parathyroid adenomas and multiple fibro-osseous tumors of the maxilla and mandible. Some families have had affected members with involvement of the kidneys, variously reported as Wilms tumors, nephroblastomas, and hamartomas. The HPT-JT gene (HRPT2) maps to chromosome 1q25-q31. We describe further investigation of two HPT-JT families (K3304 and K3349) identified through the literature. These two expanded families and two previously reported families were investigated jointly for linkage with 21 new, closely linked markers. Multipoint linkage analysis resulted in a maximum LOD score of 7.83 (at recombination fraction 0) for markers D1S2848-D1S191. Recombination events in these families reduced the HRPT2 region to approximately 14.7 cM. In addition, two of these four study families (i.e., K3304 and K11687) share a 2.2-cM length of their (expanded) affected haplotype, indicating a possible common origin. Combining the linkage data and shared-haplotype data, we propose a 0.7-cM candidate region for HRPT2.
甲状旁腺功能亢进-颌骨肿瘤综合征(HPT-JT)是一种常染色体显性疾病,其特征为多发甲状旁腺腺瘤以及上颌骨和下颌骨的多发纤维性骨肿瘤。一些家族中有肾脏受累的患病成员,不同报道称其为肾母细胞瘤、肾胚细胞瘤和错构瘤。HPT-JT基因(HRPT2)定位于1号染色体的1q25-q31区域。我们描述了对通过文献鉴定出的两个HPT-JT家族(K3304和K3349)的进一步研究。这两个扩大家族以及之前报道的两个家族共同接受了与21个新的紧密连锁标记的连锁分析。多点连锁分析得出标记D1S2848-D1S191的最大LOD值为7.83(重组率为0时)。这些家族中的重组事件将HRPT2区域缩小至约14.7厘摩。此外,这四个研究家族中的两个(即K3304和K11687)在其(扩大的)受累单倍型上有一段2.2厘摩长的共享区域,表明可能有共同起源。结合连锁数据和共享单倍型数据,我们提出了一个0.7厘摩的HRPT2候选区域。